We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Webinars

Now get all the training you need – all in one place, and all for one low price!

The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars listed below. These training programs feature top consultants, expert speakers and FDA officials.

PLUS, subscribers get automatic access to all our new training programs for the next 12 months – that’s more than 50 new programs a year!

If you are already a Training Pass member login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video click the "Download Presentation" link.

LOGIN

BUY NOW 1-Year Unlimited Access $1,297


 

Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

Webinar Training Pass

FDA’s Guidance on Drugs and Biologics During COVID-19: The Most Consequential Guidance Documents on Drug Development, cGMP & Inspections
73 minutes

Recorded on: Oct. 20, 2020

Description: FDA regulatory expert Keith Webber explains the FDA’s most important coronavirus-related guidance. He covers:

  • GMP manufacturing considerations;
  • Supply chain drug and biologics inspections; and
  • COVID-19 vaccine guidance.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Keith Webber, Senior Associate, Lachman Consultant Services

Reliability for Medical Devices: What It Is, How to Analyze It, Make It Work for You
90 minutes

Recorded on: Oct. 15, 2020

Description: Medical device regulatory expert Dan O’Leary explains the importance of medical device reliability and the tools and methods you need to prove it. He discusses:

  • The concept of maintainability;
  • Availability as the combination of reliability and maintainability;
  • Distinguishing between safety and reliability; and
  • The relationship between reliability and warranty cost.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Dan O'Leary, President, Ombu Enterprises

Pharmacy Compounding Regulation: FDA’s Latest Guidance, Compliance and Enforcement Activities
85 minutes

Recorded on: Oct. 14, 2020

Description: Regulatory expert Karla Palmer shares tips on navigating the regulation of outsourcing facilities and compounding activities. She discusses:

  • The significant differences between Sections 503A and 503B of the Food, Drug and Cosmetic Act (FDCA);
  • The FDA’s position with respect to compounding pharmacies and outsourcing facilities considering drug shortages caused by the COVID-19 pandemic;
  • The implications of recent enforcement actions the FDA has taken against compounders; and
  • The important interplay between the FDA and states concerning the regulation of outsourcing facilities and compounding pharmacies.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Karla Palmer, Attorney, Hyman, Phelps & McNamara

Make Real-Time, Real-World Data Work for You: How to Accelerate Clinical Trials and Enhance Market Access
57 minutes

Recorded on: Oct. 14, 2020

Description: Clinical trial experts Jim Coutcher, Matt Stannard and Qi Li discuss how to use real-world data (RWD) to improve trial recruitment, clinical operations and postmarket surveillance. They cover:

  • Approaches to rapid site selection, cohort identification and patient recruitment;
  • How to leverage comprehensive, longitudinal patient health records to improve clinical research, health economics and outcomes research, and market access; and
  • Where the industry is headed with concepts such as siteless randomized clinical trials, artificial cohorts for comparator arms and the role of RWD in artificial intelligence.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Jim Coutcher, Senior Director/Principal, Global Head of Enriched Studies, Real-World Solutions, IQVIA; Matt Stannard, Life Sciences Adviser, InterSystems; and Qi Li, Physician Executive, InterSystems

Revisiting Supplier Quality Agreements: A Critical Step in Managing Supply Chain Risk and Compliance
60 minutes

Recorded on: Oct. 13, 2020

Description: Quality management experts Bob Mehta and Lou Sanatore explain how a streamlined and precise supplier agreement can improve your time to market. They discuss:

  • How to hold suppliers accountable to ensure they meet quality and compliance regulations and company requirements;
  • How to demonstrate management and control over suppliers’ compliance during an audit or inspection;
  • What criteria to use to create a quality agreement if the law and/or regulatory requirements are not clear; and
  • What criteria to use to establish a process for periodic reviews of the quality agreement.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Bob Mehta, Principal Consultant, GMP ISO Expert Services, and Lou Sanatore, Principal Solution Engineer, ComplianceQuest

Make Virtual Monitoring Work for You: How eSource Helps Sponsors Monitor Virtually During COVID-19
60 minutes

Recorded on: Oct. 13, 2020

Description: Clinical trial experts Raymond Nomizu and Gail Hinkson discuss the benefits of using electronic data management systems for virtual trial monitoring. They cover:

  • Cost savings from remote monitoring;
  • Operational challenges of transition to electronic systems; and
  • How sponsors can help their sites make the transition.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Raymond Nomizu, Co-Founder and CEO, Clinical Research IO, and Gail Hinkson, CEO, Pinnacle Clinical Research

Global Unique Device Identification (UDI): Regulatory Operational Impact and Optimization
60 minutes

Recorded on: Sept. 30, 2020

Description: Regulatory affairs experts Kim Young and Monir El Azzouzi discuss the direct impact of UDI data requirements for multiple stakeholders and approaches considered across the industry to implement systems and processes. They cover:

  • Implications for manufacturers of increased visibility by regulators;
  • Compliance timelines of various UDI initiatives underway around the world; and
  • How to leverage UDI data to drive internal regulatory intelligence.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Kim Young, Director of Global Regulatory Intelligence, Instem, and Monir El Azzouzi, CEO, Easy Medical Device

POCs, IVDs and LDTs: What Medical Device Professionals Need to Know for Premarket Approval
88 minutes

Recorded on: Sept. 30, 2020

Description: Medical device regulatory experts Seth Olson and Susan Tiedy-Stevenson present the different FDA pathways to premarket approval. They discuss:

  • 510(k), De Novo, PMA and EUA considerations;
  • The effect of the newly proposed VALID Act;
  • Software as a medical device; and
  • FDA presubmission programming and strategies for informal modes of communication.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Seth Olson, FDA Medical Device Attorney, Susan Tiedy-Stevenson, Senior Director of Regulatory Sciences, Hogan Lovells

Permitted Daily Exposure/Acceptable Daily Exposure Values: The New Acceptance Criteria in Cleaning Validation
90 minutes

Recorded on: Sept. 29, 2020

Description: GMP compliance expert Sabine Paris discusses cleaning validation requirements set by the FDA and EU authorities for permitted daily exposure (PDE). She covers:

  • The new requirements of EMA, PIC/S and ASTM PDE guidelines;
  • The complex derivation of PDEs;
  • Important aspects of PDE reports; and
  • The risk identification in a multipurpose facility.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Sabine Paris, Pharmacist, Senior GMP Expert, Chief Editor of GMP Compliance Adviser

Domestic Inspections and Risk Assessment: What’s the Same and What’s Different with the FDA’s Resumed Operations?
77 minutes

Recorded on: Sept. 24, 2020

Description: Regulatory compliance expert Kalah Auchincloss shares her insights on FDA inspections during the pandemic. She discusses:

  • Developments in FDA inspections from March 2020 to July 2020;
  • The agency’s August 2020 inspections guidance; and
  • What the FDA’s inspection plans are going forward.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Kalah Auchincloss, Senior Vice President and Deputy General Counsel, Greenleaf Health

Previous 1 2 3 4 5 6 7 8 9 … 64 65 Next

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • AstraZeneca

    AstraZeneca Withdraws Imfinzi’s Bladder Cancer Indication

  • CE mark

    Cue Health’s COVID-19 Test Receives CE Mark

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing